Understanding Viral Budding: Release and Replication

Budding is the release mechanism for enveloped viruses. The viral nucleocapsid assembles at the host plasma membrane, acquires a lipid bilayer envelope studded with viral glycoproteins, and pinches off.

Steps

  1. Assembly: Viral structural proteins (matrix, capsid) and genome accumulate at cytoplasmic membrane (often lipid rafts).
  2. Envelopment: Membrane bulges outward; viral glycoproteins (spikes) insert into membrane. Matrix protein links nucleocapsid to cytoplasmic tail of glycoproteins.
  3. Scission: ESCRT machinery (host) or viral proteins (e.g., HIV Vpu, Ebola VP40) mediate membrane fission. Virion released.
  4. Maturation: Proteolytic cleavage (e.g., HIV protease) converts immature → infectious virion.

Key Features

  • Host membrane derived: Lipid composition reflects cell type (cholesterol-rich rafts).
  • Non-lytic: Cell survives (initially); allows persistent infection.
  • Polarized budding: Apical (influenza, paramyxoviruses) vs. basolateral (HIV in T cells) – determines spread route.

Examples

  • HIV (retrovirus) – buds from plasma membrane.
  • Influenza (orthomyxovirus) – buds from apical membrane.
  • Herpesviruses – bud through nuclear membrane, then Golgi, then plasma membrane (complex).
  • Coronaviruses – bud into ERGIC/Golgi, released via exocytosis (not classical budding).

Therapeutic Targets

  • Protease inhibitors (HIV) – block maturation.
  • Budding inhibitors (e.g., targeting ESCRT, Vpu) – experimental.
  • Neuraminidase inhibitors (oseltamivir) – prevent release of influenza virions from cell surface.

Budding is a defining feature of enveloped viruses and a major antiviral target.

Viral Infections - Related Articles